Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(21%)
Results Posted
50%(4 trials)

Phase Distribution

Ph phase_2
4
29%
Ph not_applicable
2
14%
Ph phase_4
6
43%
Ph phase_3
1
7%

Phase Distribution

0

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
4(30.8%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
6(46.2%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2
Active, not recruiting2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (30.8%)
Phase 31 (7.7%)
Phase 46 (46.2%)
N/A2 (15.4%)

Trials by Status

not_yet_recruiting17%
recruiting17%
unknown214%
active_not_recruiting214%
completed857%

Recent Activity

3 active trials
Showing 5 of 14
completedphase_2

The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

NCT03819322
recruitingphase_3

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

NCT07037277
active_not_recruitingphase_2

Expanding the Pool in Orthotopic Heart Transplantation

NCT03222531
active_not_recruitingphase_2

The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

NCT03809533
not_yet_recruitingnot_applicable

Hepatitis C Treatment in Idaho County Jails

NCT06533319
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT03819322Phase 2

The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

Completed
NCT07037277Phase 3

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Recruiting
NCT03222531Phase 2

Expanding the Pool in Orthotopic Heart Transplantation

Active Not Recruiting
NCT03809533Phase 2

The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

Active Not Recruiting
NCT06533319Not Applicable

Hepatitis C Treatment in Idaho County Jails

Not Yet Recruiting
NCT03057847Phase 4

Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection

Completed
NCT02836925Phase 2

Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

Completed
NCT03492112Not Applicable

A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams

Completed
NCT03086044Phase 4

Transplanting Hepatitis C Positive Organs

Unknown
NCT03235154Phase 4

A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

Completed
NCT03619837Phase 4

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Completed
NCT02064049Phase 4

Surveillance and Treatment of Prisoners With Hepatitis C

Completed
NCT03032666Phase 4

Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial

Completed
NCT02657694

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14